Polyclonal Antibodies

Polyclonal antibodies are complex mixtures of immunoglobulin molecules secreted by different B cell lineages within an immunized host. Unlike monoclonal counterparts that bind a single specific site, polyclonal antibodies possess the unique capability to recognize and bind multiple distinct epitopes on a single target antigen. Pronewbio provides a comprehensive, highly validated portfolio of polyclonal antibodies designed to accelerate discoveries across critical therapeutic areas, including oncology, neurological diseases, and gene therapy. Our proprietary immunization and purification platforms ensure that our antibodies deliver uncompromising sensitivity, robust affinity, and exceptional lot-to-lot consistency.

Schematic diagram of the differences in antigen epitope recognition between monoclonal and polyclonal antibodies.
Fig 1. Schematic comparison of epitope recognition between monoclonal and polyclonal antibodies.

The Pronewbio Advantages

As a research-driven biotechnology company, Pronewbio understands that reliable reagents are the foundation of reproducible science. Our polyclonal antibodies are engineered to meet the highest industry standards, providing distinct technical advantages for your benchwork.

Enhanced Signal Amplification: By binding to multiple epitopes on a single target molecule, our polyclonal antibodies facilitate robust signal amplification. This characteristic makes them the ideal choice for detecting low-abundance proteins in complex biological matrices where signal intensity is a limiting factor.

Superior Target Tolerance: Biological samples often present targets with structural variations due to polymorphism, post-translational modifications, or conformational changes induced during assay preparation. The multi-epitope recognition profile of Pronewbio polyclonal antibodies ensures sustained binding efficacy even when minor target alterations occur, minimizing the risk of false-negative results.

Rigorous Quality Control: Every antibody lot undergoes a stringent validation matrix. We utilize antigen-specific affinity purification techniques to isolate high-avidity fractions, followed by extensive cross-reactivity profiling against related protein families. This process effectively eliminates non-specific background signals.

Diverse Host Species

Selecting the appropriate host animal is critical for overcoming cross-reactivity and immunogenicity challenges. To ensure optimal compatibility with your multiplex assays and secondary detection systems, Pronewbio offers polyclonal antibodies raised in a wide array of premium host species:

  • Rabbit: Premier choice for high-affinity and high-titer antibody generation, including against small molecules.
  • Rat: Ideal for targeting non-murine antigens and specific secondary antibody workflows.
  • Guinea Pig: Provides greater phylogenetic distance to produce specific responses against conserved mammalian proteins.
  • Mouse: Standard host offering seamless compatibility with existing laboratory workflows.
  • Chicken: Produces IgY antibodies from eggs, offering high reactivity to mammalian targets with zero mammalian Fc receptor background noise.

Key Applications

Our polyclonal antibodies are thoroughly validated across diverse experimental platforms to guarantee optimal performance in your specific workflow.

Western Blotting: Pronewbio antibodies provide distinct, high-resolution bands for both native and denatured proteins. Recommended working dilutions typically range from 1 x 500 to 1 x 2000, ensuring economical usage without sacrificing signal-to-noise ratios.

Immunohistochemistry and Immunofluorescence: The robust binding properties of our polyclonal pool allow for excellent tissue penetration and target recognition in fixed samples, including complex tumor microenvironment sections and neural tissue organoids.

ELISA and Immunoassays: Due to their broad epitope coverage, our polyclonals serve as highly effective capture or detection antibodies in sandwich ELISA configurations, rapidly sequestering target antigens from heterogeneous sample mixtures.

Immunoprecipitation: The strong avidity of our polyclonal preparations ensures highly efficient antigen pull-down from cellular lysates, allowing for the reliable isolation of native protein complexes.

Case Study

These figures present robust multi-modality validation of our specialized rabbit polyclonal antibodies across three core experimental platforms, demonstrating highly specific delineation of complex cellular morphologies via multiplex immunofluorescence, precise target localization in brightfield immunohistochemistry tissue sections, and reliable detection in standard Western blotting protocols.

polyclonal antibodies case study

Custom Polyclonal Antibody Generation Services

Beyond our catalog offerings, Pronewbio excels in custom polyclonal antibody development tailored to highly specific research requirements. Leveraging our deep expertise in molecular biology, we manage the entire production pipeline. This includes advanced bioinformatics-guided peptide design, host animal immunization, high-titer serum collection, and final affinity purification. Our state-of-the-art facility can easily handle large-scale translational projects, routinely accommodating immune response profiling that evaluates target interactions across populations exceeding 10 M cells per assay, ensuring you receive the highest quality immunological reagents for your innovative therapies.